Reliance Pharma Fund - Direct (Bonus)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 23 May 2018 139.79 -0.91
(-0.65%)

NAV High-Low (in Rs)

ONE Mth 2035.56
2035.56
52-WEEk 1235.15
2035.56

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - 9.71 0.61
Sensex -1.38 0.13 2.92 14.39 23.99
Nifty -1.58 -0.95 1.19 12.32 24.29

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 30 Apr 2018
Category Share (%)
Cash & Cash Equivalent 0.00
Derivatives 0.36
Equity 99.04
Reverse Repo 0.76
› More
   As On 30 Apr 2018
Sector Name Amount
Finance & Investments 1.11
Healthcare 13.36
NA 1.12
Pharmaceuticals - Indian - Bulk Drugs 15.15
Pharmaceuticals - Indian - Bulk Drugs & Formln 50.22
Pharmaceuticals - Multinational 19.20
› More
   As On 30 Apr 2018
Company Name
Divi's Lab. 11.76
Abbott India 10.34
Cipla 9.55
Sun Pharma.Inds. 9.22
Sanofi India 8.86
Aurobindo Pharma 8.83
Biocon 7.56
Thyrocare Tech. 6.32
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com